WebDec 28, 2024 · Novo Nordisk has been advised by the depositary for the tender offer that almost 65 million shares of Dicerna’s common stock were validly tendered and not validly withdrawn in the tender offer as of the expiration fo the tender offer at 5 p.m. ET on Dec. 27, 2024, representing approximately 82.6% of the total number of shares of Dicerna’s ... WebDec 25, 2024 · LEXINGTON, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with Novo Nordisk’s cash tender offer for Dicerna expired at 11:59 p.m., Eastern Time, on December 24, …
Dicerna Announces Proposed Public Offering of Common Stock
WebDec 14, 2024 · Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of innovative, subcutaneously delivered RNAi-based therapeutics for diseases involving the liver, including rare diseases, chronic liver diseases, cardiovascular diseases, and viral infectious diseases. WebDec 28, 2024 · Following the expiration of Novo Nordisk’s cash tender offer for Dicerna, Novo Nordisk has today acquired all outstanding shares of common stock of Dicerna at a price of USD 38.25 per share in cash, without interest … c and t stands for
Novo Nordisk Announces Completion of Dicerna Pharmaceuticals ...
WebNov 19, 2024 · It has chosen to do so by acquiring Dicerna Pharmaceuticals ( DRNA ). It is paying an 80% premium from the closing of the stock on November 17, 2024, which was around $21.28 per share. It is... WebApr 6, 2024 · At the same time, our agreement related to lumasiran and nedosiran clears a path for each company to offer a new and differentiated treatment to patients with PH.” Under the development and commercialization agreement, Alnylam’s ALN-AAT02 and Dicerna’s DCR-A1AT, investigational RNAi therapeutics, each in Phase 1/2 … WebDicerna’s Profile, Revenue and Employees. Dicerna is a Massachusetts-based biotechnology company that develops and commercializes RNAi therapies for the … fish tank air bubble ornaments